NM_000489.6:c.3664G>A
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4BP6_ModerateBS2
The NM_000489.6(ATRX):c.3664G>A(p.Asp1222Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000149 in 1,206,487 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_000489.6 missense
Scores
Clinical Significance
Conservation
Publications
- alpha thalassemia-X-linked intellectual disability syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- ATR-X-related syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- intellectual disability-hypotonic facies syndrome, X-linked, 1Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000489.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATRX | NM_000489.6 | MANE Select | c.3664G>A | p.Asp1222Asn | missense | Exon 9 of 35 | NP_000480.3 | ||
| ATRX | NM_138270.5 | c.3550G>A | p.Asp1184Asn | missense | Exon 8 of 34 | NP_612114.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATRX | ENST00000373344.11 | TSL:1 MANE Select | c.3664G>A | p.Asp1222Asn | missense | Exon 9 of 35 | ENSP00000362441.4 | ||
| ATRX | ENST00000395603.7 | TSL:1 | c.3550G>A | p.Asp1184Asn | missense | Exon 8 of 34 | ENSP00000378967.3 | ||
| ATRX | ENST00000624166.3 | TSL:1 | c.3460G>A | p.Asp1154Asn | missense | Exon 9 of 14 | ENSP00000485103.1 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111119Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000167 AC: 3AN: 179139 AF XY: 0.0000156 show subpopulations
GnomAD4 exome AF: 0.0000146 AC: 16AN: 1095368Hom.: 0 Cov.: 30 AF XY: 0.0000166 AC XY: 6AN XY: 361092 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111119Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33341 show subpopulations
ClinVar
Submissions by phenotype
Alpha thalassemia-X-linked intellectual disability syndrome Uncertain:1Benign:1
ATRX-related disorder Uncertain:1
The ATRX c.3664G>A variant is predicted to result in the amino acid substitution p.Asp1222Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0037% of alleles in individuals of European (Non-Finnish) descent in gnomAD, including one hemizygous individual. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at